BIOMAT Database Logo BIOMAT Database Logo

Anti-HCV testing in autoimmune hepatitis and primary biliary cirrhosis. 1990

M Fusconi, and M Lenzi, and G Ballardini, and R Miniero, and F Cassani, and D Zauli, and F B Bianchi

UI MeSH Term Description Entries
D008105 Liver Cirrhosis, Biliary FIBROSIS of the hepatic parenchyma due to obstruction of BILE flow (CHOLESTASIS) in the intrahepatic or extrahepatic bile ducts (BILE DUCTS, INTRAHEPATIC; BILE DUCTS, EXTRAHEPATIC). Primary biliary cholangitis involves the destruction of small intra-hepatic bile ducts and decreased bile secretion. Secondary biliary cholangitis is produced by prolonged obstruction of large intrahepatic or extrahepatic bile ducts from a variety of causes. Biliary Cirrhosis,Biliary Cirrhosis, Primary,Biliary Cirrhosis, Secondary,Cholangitis, Chronic Nonsuppurative Destructive,Liver Cirrhosis, Obstructive,Primary Biliary Cholangitis,Biliary Cirrhosis, Primary, 1,Primary Biliary Cirrhosis,Secondary Biliary Cholangitis,Secondary Biliary Cirrhosis,Biliary Cholangitides, Primary,Biliary Cholangitis, Primary,Biliary Cholangitis, Secondary,Cholangitides, Primary Biliary,Cholangitis, Primary Biliary,Cholangitis, Secondary Biliary,Cirrhosis, Biliary,Cirrhosis, Secondary Biliary,Liver Cirrhoses, Biliary,Obstructive Liver Cirrhosis,Primary Biliary Cholangitides,Secondary Biliary Cholangitides
D004797 Enzyme-Linked Immunosorbent Assay An immunoassay utilizing an antibody labeled with an enzyme marker such as horseradish peroxidase. While either the enzyme or the antibody is bound to an immunosorbent substrate, they both retain their biologic activity; the change in enzyme activity as a result of the enzyme-antibody-antigen reaction is proportional to the concentration of the antigen and can be measured spectrophotometrically or with the naked eye. Many variations of the method have been developed. ELISA,Assay, Enzyme-Linked Immunosorbent,Assays, Enzyme-Linked Immunosorbent,Enzyme Linked Immunosorbent Assay,Enzyme-Linked Immunosorbent Assays,Immunosorbent Assay, Enzyme-Linked,Immunosorbent Assays, Enzyme-Linked
D006508 Hepatitis Antibodies Immunoglobulins raised by any form of viral hepatitis; some of these antibodies are used to diagnose the specific kind of hepatitis. Antibodies, Hepatitis
D006521 Hepatitis, Chronic INFLAMMATION of the LIVER with ongoing hepatocellular injury for 6 months or more, characterized by NECROSIS of HEPATOCYTES and inflammatory cell (LEUKOCYTES) infiltration. Chronic hepatitis can be caused by viruses, medications, autoimmune diseases, and other unknown factors. Chronic Hepatitis,Cryptogenic Chronic Hepatitis,Hepatitis, Chronic, Cryptogenic,Hepatitis, Chronic Active,Hepatitis, Chronic Persistent,Chronic Active Hepatitis,Chronic Hepatitis, Cryptogenic,Chronic Persistent Hepatitides,Chronic Persistent Hepatitis,Hepatitis, Cryptogenic Chronic
D006525 Hepatitis, Viral, Human INFLAMMATION of the LIVER in humans due to infection by VIRUSES. There are several significant types of human viral hepatitis with infection caused by enteric-transmission (HEPATITIS A; HEPATITIS E) or blood transfusion (HEPATITIS B; HEPATITIS C; and HEPATITIS D). Viral Hepatitis, Human,Human Viral Hepatitides,Human Viral Hepatitis,Viral Hepatitides, Human
D006526 Hepatitis C INFLAMMATION of the LIVER in humans caused by HEPATITIS C VIRUS, a single-stranded RNA virus. Its incubation period is 30-90 days. Hepatitis C is transmitted primarily by contaminated blood parenterally and is often associated with transfusion and intravenous drug abuse. However, in a significant number of cases, the source of hepatitis C infection is unknown. Hepatitis, Viral, Non-A, Non-B, Parenterally-Transmitted,Parenterally-Transmitted Non-A, Non-B Hepatitis,PT-NANBH,Parenterally Transmitted Non A, Non B Hepatitis
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D001327 Autoimmune Diseases Disorders that are characterized by the production of antibodies that react with host tissues or immune effector cells that are autoreactive to endogenous peptides. Autoimmune Disease,Disease, Autoimmune,Diseases, Autoimmune
D015151 Immunoblotting Immunologic method used for detecting or quantifying immunoreactive substances. The substance is identified by first immobilizing it by blotting onto a membrane and then tagging it with labeled antibodies. Dot Immunoblotting,Electroimmunoblotting,Immunoelectroblotting,Reverse Immunoblotting,Immunoblotting, Dot,Immunoblotting, Reverse,Dot Immunoblottings,Electroimmunoblottings,Immunoblottings,Immunoblottings, Dot,Immunoblottings, Reverse,Immunoelectroblottings,Reverse Immunoblottings

Related Publications

M Fusconi, and M Lenzi, and G Ballardini, and R Miniero, and F Cassani, and D Zauli, and F B Bianchi
[Primary biliary cirrhosis and the overlap syndrome of primary biliary cirrhosis and autoimmune hepatitis].
November 2008, Annales de pathologie,
M Fusconi, and M Lenzi, and G Ballardini, and R Miniero, and F Cassani, and D Zauli, and F B Bianchi
Autoimmune Hepatitis - Primary Biliary Cirrhosis Overlap Syndrome.
July 2017, Journal of clinical and diagnostic research : JCDR,
M Fusconi, and M Lenzi, and G Ballardini, and R Miniero, and F Cassani, and D Zauli, and F B Bianchi
Evolution from primary biliary cirrhosis to primary biliary cirrhosis/autoimmune hepatitis overlap syndrome.
February 2008, Seminars in liver disease,
M Fusconi, and M Lenzi, and G Ballardini, and R Miniero, and F Cassani, and D Zauli, and F B Bianchi
Autoimmune chronic active hepatitis and primary biliary cirrhosis.
January 1989, Bailliere's clinical gastroenterology,
M Fusconi, and M Lenzi, and G Ballardini, and R Miniero, and F Cassani, and D Zauli, and F B Bianchi
Primary biliary cirrhosis and autoimmune hepatitis overlap syndrome.
January 2004, Indian journal of gastroenterology : official journal of the Indian Society of Gastroenterology,
M Fusconi, and M Lenzi, and G Ballardini, and R Miniero, and F Cassani, and D Zauli, and F B Bianchi
[Autoimmune hepatitis and primary biliary cirrhosis overlap syndrome].
December 2004, Presse medicale (Paris, France : 1983),
M Fusconi, and M Lenzi, and G Ballardini, and R Miniero, and F Cassani, and D Zauli, and F B Bianchi
Development of autoimmune hepatitis in primary biliary cirrhosis.
October 2007, Liver international : official journal of the International Association for the Study of the Liver,
M Fusconi, and M Lenzi, and G Ballardini, and R Miniero, and F Cassani, and D Zauli, and F B Bianchi
Apoptotic pathways in primary biliary cirrhosis and autoimmune hepatitis.
August 2001, Liver,
M Fusconi, and M Lenzi, and G Ballardini, and R Miniero, and F Cassani, and D Zauli, and F B Bianchi
["Overlap" syndromes. Autoimmune hepatitis--primary biliary liver cirrhosis; autoimmune hepatitis--primary sclerosing cholangitis].
January 2001, Presse medicale (Paris, France : 1983),
M Fusconi, and M Lenzi, and G Ballardini, and R Miniero, and F Cassani, and D Zauli, and F B Bianchi
Primary biliary cirrhosis and autoimmune hepatitis: apotopes and epitopes.
January 2011, Journal of gastroenterology,
Copied contents to your clipboard!